Vai al contenuto principale della pagina
Autore: | Vissers Maud N |
Titolo: | Evidence-based management of lipid disorders / / Maud N. Vissers, John J.P. Kastelein, Erik S. Stroes, [editors] |
Pubblicazione: | Harley : , : TFM, , 2010 |
Descrizione fisica: | 1 online resource (322 p.) |
Disciplina: | 616.399706 |
Soggetto topico: | Lipids - Metabolism - Disorders - Treatment |
Evidence-based medicine | |
Altri autori: | VissersMaud N KasteleinJohn J. P StroesErik S |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references and index. |
Nota di contenuto: | ""COVER FRONT""; ""Contents""; ""Foreword""; ""Contributors""; ""Acknowledgements""; ""Using evidence-based medicine""; ""Chapter 1 How much evidence is enough?""; ""Chapter 2 A brief review of lipoprotein metabolism""; ""Chapter 3 Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases""; ""Chapter 4 Are LDL cholesterol-lowering functional food ingredients successful in the long term?""; ""Chapter 5 Evidence-based treatment of primary hypo- and hypercholesterolemic disorders""; ""Chapter 6 Does raising HDL protect against atherosclerosis?"" |
""Chapter 7 How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment?""""Chapter 8 The optimal treatment of patients with familial combined hyperlipidemia""; ""Chapter 9 How to manage lipid and lipoprotein disorders in children""; ""Chapter 10 Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus""; ""Chapter 11 What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels?"" | |
""Chapter 12 The link between chronic inflammatory diseases and cardiovascular risk""""Chapter 13 What is the evidence for a physiological and pathogenic role of lipoprotein (a)?""; ""Chapter 14 Sitosterolemia; xenophobia for the body""; ""Chapter 15 How can we deal with inborn errors in cholesterol and bile acid biosynthesis?""; ""Chapter 16 Differential diagnosis of patients with xanthomas and xanthelasmata""; ""Chapter 17 When should we fear statin interactions?""; ""Chapter 18 What are the considerations in patients who are statin �intolerant�?""; ""Index""; ""COVER BACK"" | |
Titolo autorizzato: | Evidence-based management of lipid disorders |
ISBN: | 1-908986-59-X |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910789125703321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |